Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

ABDULLAHI, GEZMAN

NPI: 1225394380 · SYLMAR, CA 91342 · Student in an Organized Health Care Education/Training Program · NPI assigned 04/03/2012

$0.00
Total Medicaid Paid
28,286
Total Claims
25,214
Beneficiaries
70
Codes Billed
2022-02
First Month
2024-12
Last Month

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2022 3,536 $0.00
2023 9,764 $0.00
2024 14,986 $0.00

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
83735 696 526 $0.00
90686 123 123 $0.00
J7050 Infusion, normal saline solution, 250 cc 198 143 $0.00
90677 12 12 $0.00
83036 Hemoglobin; glycosylated (A1C) 1,755 1,737 $0.00
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 770 763 $0.00
82728 341 334 $0.00
36415 Collection of venous blood by venipuncture 4,392 3,576 $0.00
3079F 132 129 $0.00
80048 Basic metabolic panel (calcium, ionized) 1,178 1,085 $0.00
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1,632 1,389 $0.00
87522 Neg quan hep c or qual rna 320 316 $0.00
81001 394 367 $0.00
80053 Comprehensive metabolic panel 1,707 1,392 $0.00
82043 596 577 $0.00
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed 434 429 $0.00
83550 320 314 $0.00
3044F 309 306 $0.00
87086 Culture, bacterial; quantitative colony count, urine 54 53 $0.00
87340 107 107 $0.00
3074F 658 603 $0.00
3075F 238 233 $0.00
92250 17 17 $0.00
99443 38 38 $0.00
82607 174 172 $0.00
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 545 539 $0.00
85652 25 25 $0.00
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1,132 1,092 $0.00
84443 Thyroid stimulating hormone (TSH) 193 190 $0.00
1111F 160 149 $0.00
85027 562 514 $0.00
86141 29 27 $0.00
82746 67 66 $0.00
90656 69 69 $0.00
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 46 46 $0.00
3052F 28 28 $0.00
97010 85 42 $0.00
99441 12 12 $0.00
86706 99 99 $0.00
90674 15 15 $0.00
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 32 32 $0.00
83540 326 320 $0.00
82570 201 190 $0.00
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 51 37 $0.00
84100 322 261 $0.00
82274 289 288 $0.00
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 540 265 $0.00
80061 Lipid panel 1,308 1,293 $0.00
3078F 914 836 $0.00
86480 190 182 $0.00
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 271 256 $0.00
77067 Screening mammography, bilateral, including computer-aided detection 100 100 $0.00
82540 596 577 $0.00
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 2,072 1,631 $0.00
86703 334 333 $0.00
85610 399 293 $0.00
81003 16 13 $0.00
77062 59 59 $0.00
90653 30 30 $0.00
3051F 38 38 $0.00
84439 24 24 $0.00
3077F 235 228 $0.00
86705 39 39 $0.00
83970 13 12 $0.00
80076 57 56 $0.00
99442 45 45 $0.00
90750 30 30 $0.00
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 13 13 $0.00
3046F 55 54 $0.00
90661 25 25 $0.00